Filing Details

Accession Number:
0001038133-16-000277
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-07 13:26:56
Reporting Period:
2016-07-06
Filing Date:
2016-07-07
Accepted Time:
2016-07-07 13:26:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA Biological Products, (No Disgnostic Substances) (2836) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1570492 S. Kevin Wilson 3760 Rocky Mountain Avenue
Loveland CO 80538
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-07-06 5,960 $40.27 160,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 124,099 Indirect by Cuattro, LLC
Common Stock 13,432 Indirect by Daughter
Common Stock 13,432 Indirect by Son
Common Stock 13,432 Indirect by Son II
Common Stock 13,432 Indirect by Son III
Common Stock 20,092 Indirect by Spouse
Common Stock 138,743 Indirect by Wilson Family Tr.
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 3, 2016.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.95 to $40.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.